The introduction of molecular biology techniques to the field of trans
fusion medicine has allowed more detailed analysis of the basis for th
e expression of several blood-group antigens. The application of the p
olymerase chain reaction for the determination of red-cell blood-group
genotype is a highly sensitive technique that can be used to determin
e the likelihood of a fetus being affected by haemolytic disease of th
e fetus or newborn. This alone makes polymerase chain reaction based t
echniques highly desirable for such applications. The determination of
the genetic basis for the Kell/Cellano polymorphism has enabled the d
evelopment of polymerase chain reaction-based techniques for genotypin
g, Several other red-cell blood-group antigen pol morphisms can also b
e analysed in this way.